Very quickly, I appreciate the statements and the question with respect to national treatment. Without taking any position on the utility of investor-state provisions, without making any comments with respect that matter, I think it's very important to distinguish between a number of the provisions that are within chapter 11. Article 1102, which deals with national treatment, is entirely distinct from article 1105, which deals with the minimum standard of treatment. National treatment deals with the fact that Canadian investors are going to have to be treated the same as U.S. investors. The minimum standard of treatment deals with an objective standard of treatment that any investor must be granted.
Dow is not claiming that Canadian investors were treated more favourably. There's no article 1102 claim. This is about article 1105 and the minimum standard of treatment.
I think what we need to do is start drilling down into this issue and look at what wording in chapter 11 is simply not working right now. As I pointed out, the main issue is determining what is a compensable expropriation versus what is a non-compensable regulation. That's the key issue. The problem is that NAFTA, chapter 11, doesn't specify well enough. There's a raging debate out there as to what kind of regulations should be non-compensable. We really need the Canadian government to take a firm position and a very transparent position as to what they feel is non-compensable regulation. I think that's the core issue here.